Network-based ranking methods for prediction of novel disease associated microRNAs

BACKGROUND Many studies have shown roles of microRNAs on human disease and a number of computational methods have been proposed to predict such associations by ranking candidate microRNAs according to their relevance to a disease. Among them, machine learning-based methods usually have a limitation in specifying non-disease microRNAs as negative training samples. Meanwhile, network-based methods are becoming dominant since they well exploit a "disease module" principle in microRNA functional similarity networks. Of which, random walk with restart (RWR) algorithm-based method is currently state-of-the-art. The use of this algorithm was inspired from its success in predicting disease gene because the "disease module" principle also exists in protein interaction networks. Besides, many algorithms designed for webpage ranking have been successfully applied in ranking disease candidate genes because web networks share topological properties with protein interaction networks. However, these algorithms have not yet been utilized for disease microRNA prediction. METHODS We constructed microRNA functional similarity networks based on shared targets of microRNAs, and then we integrated them with a microRNA functional synergistic network, which was recently identified. After analyzing topological properties of these networks, in addition to RWR, we assessed the performance of (i) PRINCE (PRIoritizatioN and Complex Elucidation), which was proposed for disease gene prediction; (ii) PageRank with Priors (PRP) and K-Step Markov (KSM), which were used for studying web networks; and (iii) a neighborhood-based algorithm. RESULTS Analyses on topological properties showed that all microRNA functional similarity networks are small-worldness and scale-free. The performance of each algorithm was assessed based on average AUC values on 35 disease phenotypes and average rankings of newly discovered disease microRNAs. As a result, the performance on the integrated network was better than that on individual ones. In addition, the performance of PRINCE, PRP and KSM was comparable with that of RWR, whereas it was worst for the neighborhood-based algorithm. Moreover, all the algorithms were stable with the change of parameters. Final, using the integrated network, we predicted six novel miRNAs (i.e., hsa-miR-101, hsa-miR-181d, hsa-miR-192, hsa-miR-423-3p, hsa-miR-484 and hsa-miR-98) associated with breast cancer. CONCLUSIONS Network-based ranking algorithms, which were successfully applied for either disease gene prediction or for studying social/web networks, can be also used effectively for disease microRNA prediction.

[1]  Geng Chen,et al.  Towards the understanding of microRNA and environmental factor interactions and their relationships to human diseases , 2012, Scientific Reports.

[2]  Y. Moreau,et al.  Computational tools for prioritizing candidate genes: boosting disease gene discovery , 2012, Nature Reviews Genetics.

[3]  Rajeev Motwani,et al.  The PageRank Citation Ranking : Bringing Order to the Web , 1999, WWW 1999.

[4]  Yadong Wang,et al.  Weighted Network-Based Inference of Human MicroRNA-Disease Associations , 2010, 2010 Fifth International Conference on Frontier of Computer Science and Technology.

[5]  M. Kay State-of-the-art gene-based therapies: the road ahead , 2011, Nature Reviews Genetics.

[6]  Yadong Wang,et al.  Predicting human microRNA-disease associations based on support vector machine , 2013, Int. J. Data Min. Bioinform..

[7]  Yun Xiao,et al.  MiRNA–miRNA synergistic network: construction via co-regulating functional modules and disease miRNA topological features , 2010, Nucleic acids research.

[8]  Marianne Barrier,et al.  Role of miRNA and miRNA processing factors in development and disease. , 2006, Birth defects research. Part C, Embryo today : reviews.

[9]  Trey Ideker,et al.  Cytoscape 2.8: new features for data integration and network visualization , 2010, Bioinform..

[10]  M. Esteller Non-coding RNAs in human disease , 2011, Nature Reviews Genetics.

[11]  Duc-Hau Le,et al.  GPEC: A Cytoscape plug-in for random walk-based gene prioritization and biomedical evidence collection , 2012, Comput. Biol. Chem..

[12]  Qiong Shao,et al.  MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. , 2008, RNA.

[13]  Dan Jones Steps on the road to personalized medicine , 2007, Nature Reviews Drug Discovery.

[14]  E. Olson,et al.  Toward microRNA-based therapeutics for heart disease: the sense in antisense. , 2008, Circulation research.

[15]  Roded Sharan,et al.  Associating Genes and Protein Complexes with Disease via Network Propagation , 2010, PLoS Comput. Biol..

[16]  N. Rajewsky,et al.  The evolution of gene regulation by transcription factors and microRNAs , 2007, Nature Reviews Genetics.

[17]  C. Burge,et al.  The microRNAs of Caenorhabditis elegans. , 2003, Genes & development.

[18]  R. Aharonov,et al.  Identification of hundreds of conserved and nonconserved human microRNAs , 2005, Nature Genetics.

[19]  Duc-Hau Le,et al.  Neighbor-favoring weight reinforcement to improve random walk-based disease gene prioritization , 2013, Comput. Biol. Chem..

[20]  Dong Wang,et al.  Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases , 2010, Bioinform..

[21]  Yadong Wang,et al.  Prioritization of disease microRNAs through a human phenome-microRNAome network , 2010, BMC Systems Biology.

[22]  Fidel Ramírez,et al.  Computing topological parameters of biological networks , 2008, Bioinform..

[23]  Xing Chen,et al.  RWRMDA: predicting novel human microRNA-disease associations. , 2012, Molecular bioSystems.

[24]  Lin He,et al.  MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature reviews genetics.

[25]  Israel Steinfeld,et al.  miRNA target enrichment analysis reveals directly active miRNAs in health and disease , 2012, Nucleic acids research.

[26]  Padhraic Smyth,et al.  Algorithms for estimating relative importance in networks , 2003, KDD '03.

[27]  Peter Devilee,et al.  A 7 Mb region within 11q13 may contain a high penetrance gene for breast cancer , 2009, Breast Cancer Research and Treatment.

[28]  D. Bartel MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[29]  C. Burge,et al.  Prediction of Mammalian MicroRNA Targets , 2003, Cell.

[30]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[31]  Domenica Taruscio,et al.  The Role of microRNAs in the Biology of Rare Diseases , 2011, International journal of molecular sciences.

[32]  Yun Xiao,et al.  Prioritizing Candidate Disease miRNAs by Topological Features in the miRNA Target–Dysregulated Network: Case Study of Prostate Cancer , 2011, Molecular Cancer Therapeutics.

[33]  D. Vitkup,et al.  Network properties of genes harboring inherited disease mutations , 2008, Proceedings of the National Academy of Sciences.

[34]  Carl Kingsford,et al.  The power of protein interaction networks for associating genes with diseases , 2010, Bioinform..

[35]  Hailin Chen,et al.  Prediction of Associations between OMIM Diseases and MicroRNAs by Random Walk on OMIM Disease Similarity Network , 2013, TheScientificWorldJournal.

[36]  Yadong Wang,et al.  Predicting human microRNA-disease associations based on support vector machine , 2010, 2010 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).

[37]  Guohua Wang,et al.  An approach for prioritizing disease-related microRNAs based on genomic data integration , 2010, 2010 3rd International Conference on Biomedical Engineering and Informatics.

[38]  M. Oti,et al.  The modular nature of genetic diseases , 2006, Clinical genetics.

[39]  Michael Kertesz,et al.  The role of site accessibility in microRNA target recognition , 2007, Nature Genetics.

[40]  B. Bao,et al.  Expression of microRNAs: potential molecular link between obesity, diabetes and cancer , 2011, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[41]  Eugene Berezikov,et al.  Controlling miRNA regulation in disease. , 2012, Methods in molecular biology.

[42]  Jagdish Chandra Patra,et al.  Genome-wide inferring gene-phenotype relationship by walking on the heterogeneous network , 2010, Bioinform..

[43]  Q. Cui,et al.  An Analysis of Human MicroRNA and Disease Associations , 2008, PloS one.

[44]  Mohammed Al-Shalalfa,et al.  Protein network-based Lasso regression model for the construction of disease-miRNA functional interactions , 2013, EURASIP J. Bioinform. Syst. Biol..

[45]  Maricel G. Kann,et al.  Advances in translational bioinformatics: computational approaches for the hunting of disease genes , 2010, Briefings Bioinform..

[46]  Beverly L. Davidson,et al.  Current prospects for RNA interference-based therapies , 2011, Nature Reviews Genetics.

[47]  A. Näär,et al.  MicroRNAs in metabolism and metabolic disorders , 2012, Nature Reviews Molecular Cell Biology.

[48]  Zaida García-Casado,et al.  MicroRNA signatures in hereditary breast cancer , 2013, Breast Cancer Research and Treatment.

[49]  Yang Li,et al.  HMDD v2.0: a database for experimentally supported human microRNA and disease associations , 2013, Nucleic Acids Res..

[50]  Stefano Volinia,et al.  Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer , 2013, Proceedings of the National Academy of Sciences.

[51]  Mario Albrecht,et al.  Recent approaches to the prioritization of candidate disease genes , 2012, Wiley interdisciplinary reviews. Systems biology and medicine.

[52]  Q. Cui,et al.  Prediction of Disease-Related Interactions between MicroRNAs and Environmental Factors Based on a Semi-Supervised Classifier , 2012, PloS one.

[53]  Jing Chen,et al.  Disease candidate gene identification and prioritization using protein interaction networks , 2009, BMC Bioinformatics.

[54]  Irena Melnikova,et al.  RNA-based therapies , 2007, Nature Reviews Drug Discovery.

[55]  Ana Kozomara,et al.  miRBase: annotating high confidence microRNAs using deep sequencing data , 2013, Nucleic Acids Res..

[56]  C. Burge,et al.  Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.

[57]  George A Calin,et al.  Functional relevance of miRNA sequences in human disease. , 2012, Mutation research.

[58]  Kenneth Lundstrom,et al.  Micro-RNA in disease and gene therapy. , 2011, Current drug discovery technologies.

[59]  P. Robinson,et al.  Walking the interactome for prioritization of candidate disease genes. , 2008, American journal of human genetics.

[60]  Bart De Moor,et al.  A guide to web tools to prioritize candidate genes , 2011, Briefings Bioinform..

[61]  Ali Masoudi-Nejad,et al.  RETRACTED ARTICLE: Candidate gene prioritization , 2012, Molecular Genetics and Genomics.

[62]  Yadong Wang,et al.  miR2Disease: a manually curated database for microRNA deregulation in human disease , 2008, Nucleic Acids Res..

[63]  Chao Gao,et al.  miRNA mediated up-regulation of cochaperone p23 acts as an anti-apoptotic factor in childhood acute lymphoblastic leukemia. , 2012, Leukemia research.

[64]  J. Mendell,et al.  MicroRNAs in Stress Signaling and Human Disease , 2012, Cell.

[65]  Yu Li,et al.  MicroRNAs in Common Human Diseases , 2012, Genom. Proteom. Bioinform..

[66]  A. Barabasi,et al.  The human disease network , 2007, Proceedings of the National Academy of Sciences.

[67]  Desmond J. Higham,et al.  GeneRank: Using search engine technology for the analysis of microarray experiments , 2005, BMC Bioinformatics.